ArticleInternational journal of molecular sciences2023

Targeting AHR Increases Pancreatic Cancer Cell Sensitivity to Gemcitabine through the ELAVL1-DCK Pathway.

Darius Stukas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.